Joo-Hyun Hong

501 total citations
37 papers, 337 citations indexed

About

Joo-Hyun Hong is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Joo-Hyun Hong has authored 37 papers receiving a total of 337 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Molecular Biology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Joo-Hyun Hong's work include Cancer Immunotherapy and Biomarkers (4 papers), Natural product bioactivities and synthesis (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Joo-Hyun Hong is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Natural product bioactivities and synthesis (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Joo-Hyun Hong collaborates with scholars based in South Korea, Iran and India. Joo-Hyun Hong's co-authors include Ki Hyun Kim, Seongpil An, Hamed Hamishehkar, Sam S. Yoon, Soraya Babaie, Arezou Taghvimi, Ki‐Moon Park, Won Hee Jung, Da Eun Lee and Seokyoon Jang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

Joo-Hyun Hong

37 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joo-Hyun Hong South Korea 12 90 74 61 53 44 37 337
Tomohiko Sano Japan 14 68 0.8× 119 1.6× 29 0.5× 21 0.4× 28 0.6× 26 413
Raunak Kumar Das India 11 46 0.5× 38 0.5× 66 1.1× 21 0.4× 16 0.4× 38 422
María de Jesús Loera‐Arias Mexico 14 49 0.5× 203 2.7× 69 1.1× 23 0.4× 25 0.6× 48 572
Haiyan Hu China 13 40 0.4× 252 3.4× 92 1.5× 32 0.6× 22 0.5× 21 505
Xiaolei Cheng China 12 37 0.4× 125 1.7× 22 0.4× 26 0.5× 20 0.5× 35 481
Kyungtaek Im South Korea 10 86 1.0× 185 2.5× 74 1.2× 14 0.3× 47 1.1× 16 464
Ujjwal R. Dahiya India 8 45 0.5× 90 1.2× 82 1.3× 18 0.3× 13 0.3× 20 341
Min‐Jung Son South Korea 10 31 0.3× 224 3.0× 79 1.3× 27 0.5× 58 1.3× 16 426

Countries citing papers authored by Joo-Hyun Hong

Since Specialization
Citations

This map shows the geographic impact of Joo-Hyun Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joo-Hyun Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joo-Hyun Hong more than expected).

Fields of papers citing papers by Joo-Hyun Hong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joo-Hyun Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joo-Hyun Hong. The network helps show where Joo-Hyun Hong may publish in the future.

Co-authorship network of co-authors of Joo-Hyun Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Joo-Hyun Hong. A scholar is included among the top collaborators of Joo-Hyun Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joo-Hyun Hong. Joo-Hyun Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Hyung‐Don, Sun Jin Sym, Hong Jae Chon, et al.. (2025). Multicenter single-arm phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab. Journal of Hepatology. 84(2). 308–315. 3 indexed citations
2.
Hong, Joo-Hyun, et al.. (2024). Deodeokaloid, a New Indole Alkaloid N-Glycoside and Bioactive Phenolic Compounds from the Roots of Codonopsis lanceolata. Plants. 13(22). 3243–3243. 1 indexed citations
3.
Hong, Joo-Hyun, Ghee Young Kwon, Minyong Kang, Seong Il Seo, & Se Hoon Park. (2024). Clinical Characteristics and Outcomes of TFE3-Rearranged/TFEB-Altered Renal Cell Carcinoma with Systemic Therapies, Including Tyrosine Kinase Inhibitors or Immune Checkpoint Inhibitors: An Observational Study. SHILAP Revista de lepidopterología. 22(1). 59–67. 1 indexed citations
5.
Lim, Jae Sung, Joo-Hyun Hong, Da Young Lee, et al.. (2023). 6-Pentyl-α-Pyrone from Trichoderma gamsii Exert Antioxidant and Anti-Inflammatory Properties in Lipopolysaccharide-Stimulated Mouse Macrophages. Antioxidants. 12(12). 2028–2028. 6 indexed citations
6.
Hwang, Su Jung, et al.. (2023). 1,8-Dihydroxy-3-methoxy-anthraquinone inhibits tumor angiogenesis through HIF-1α downregulation. Biochemical Pharmacology. 220. 115972–115972. 6 indexed citations
8.
Hong, Joo-Hyun, Seon‐Hee Kim, Jin‐Chul Kim, et al.. (2022). Anti-Osteoporosis Effects of the Fruit of Sea Buckthorn (Hippophae rhamnoides) through Promotion of Osteogenic Differentiation in Ovariectomized Mice. Nutrients. 14(17). 3604–3604. 11 indexed citations
9.
Lee, Da Eun, Joo-Hyun Hong, Bora Kim, et al.. (2022). Phytochemical Investigation of Marker Compounds from Indigenous Korean Salix Species and Their Antimicrobial Effects. Plants. 12(1). 104–104. 6 indexed citations
10.
Jo, Hyunji, Seri Park, Hye Ryeon Kim, et al.. (2022). Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort. Cancers. 14(19). 4839–4839. 6 indexed citations
11.
Jo, Hyunji, Joo-Hyun Hong, Hong-Sik Kim, et al.. (2022). A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell Carcinoma. Frontiers in Oncology. 12. 874385–874385. 1 indexed citations
12.
Nguyen, Q.N., Seoung Rak Lee, Joo-Hyun Hong, et al.. (2022). Estrogenic Activity of 4-Hydroxy-Benzoic Acid from Acer tegmentosum via Estrogen Receptor α-Dependent Signaling Pathways. Plants. 11(23). 3387–3387. 7 indexed citations
13.
Babaie, Soraya, Arezou Taghvimi, Joo-Hyun Hong, et al.. (2022). Recent advances in pain management based on nanoparticle technologies. Journal of Nanobiotechnology. 20(1). 290–290. 40 indexed citations
14.
Kim, Hana, Hyo Jung Kim, Hong-Sik Kim, et al.. (2021). Real-World Data from a Refractory Triple-Negative Breast Cancer Cohort Selected Using a Clinical Data Warehouse Approach. Cancers. 13(22). 5835–5835. 9 indexed citations
17.
Hong, Joo-Hyun, Youjin Kim, Jang Ho Cho, et al.. (2018). Clinical features and prognosis of breast cancer with gastric metastasis. Oncology Letters. 17(2). 1833–1841. 20 indexed citations
18.
Jang, Yeongseon, Seokyoon Jang, Joo-Hyun Hong, et al.. (2015). Comparison of the Diversity of Basidiomycetes from Dead Wood of the Manchurian fir (Abies holophylla) as Evaluated by Fruiting Body Collection, Mycelial Isolation, and 454 Sequencing. Microbial Ecology. 70(3). 634–645. 16 indexed citations
19.
Lee, Hanbyul, Young Min Lee, Young Mok Heo, et al.. (2015). Halo-tolerance of Marine-derived Fungi and their Enzymatic Properties. BioResources. 10(4). 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026